FHIR IG analytics| Package | nictiz.fhir.nl.r4.zib2020 |
| Resource Type | CodeSystem |
| Id | CodeSystem-WHO_Anatomical_Therapeutic_Chemical_classification-atc.json |
| FHIR Version | R4 |
| Source | https://simplifier.net/resolve?scope=nictiz.fhir.nl.r4.zib2020@0.12.0-labtrial.1&canonical=http://www.whocc.no/atc |
| URL | http://www.whocc.no/atc |
| Version | 2011-02-23T12:00:00 |
| Status | unknown |
| Name | WHO_Anatomical_Therapeutic_Chemical_classification |
| Title | WHO Anatomical Therapeutic Chemical classification |
| Realm | nl |
| Authority | hl7 |
| Description | WHO ATC, Anatomical Therapeutic Chemical classification. The classification system divides drugs into different groups according to the organ or system on which they act and/or their therapeutic and chemical characteristics. It contains several subsets. |
| Content | not-present |
| ConceptMap | |
| IMMZ.Z.ConceptMap | ConceptMap to and from IMMZ.Z DataElements |
| StructureDefinition | |
| NLLMedication | NLLMedication |
| ValueSet | |
| eHDSIActiveIngredient | eHDSI Active Ingredient |
| eHDSIVaccine | eHDSI Vaccine |
| krcore-atc-codes | ATC Codes |
| atc-code | ATC codes |
| drugsAtc-eu-i4rc | Antineoplastic and immunostimulating agents |
| who-atc | WHO ATC |
| atcClassification | WHO ATC |
| vaccines-whoatc-uv-ips | Vaccines WHO ATC - IPS |
| whoatc-uv-ips | WHO ATC - IPS |
| atcClassification | WHO ATC |
| medcation-atc-tw | 臺灣食藥署藥品藥理治療分類ATC碼值集 |
| drugsAtc-eu-pcsp | Antineoplastic and immunostimulating agents |
| IMMZ.Z.DE1 | IMMZ.Z.DE1 ValueSet for BCG vaccines |
| IMMZ.Z.DE10 | IMMZ.Z.DE10 ValueSet for Meningococcal vaccines |
| IMMZ.Z.DE11 | IMMZ.Z.DE11 ValueSet for Mumps-containing vaccines |
| IMMZ.Z.DE12 | IMMZ.Z.DE12 ValueSet for Pertussis-containing vaccines |
| IMMZ.Z.DE13 | IMMZ.Z.DE13 ValueSet for Pneumococcal vaccines |
| IMMZ.Z.DE14 | IMMZ.Z.DE14 ValueSet for Poliovirus-containing vaccines |
| IMMZ.Z.DE15 | IMMZ.Z.DE15 ValueSet for Rabies vaccines |
| IMMZ.Z.DE16 | IMMZ.Z.DE16 ValueSet for Rotavirus vaccines |
| IMMZ.Z.DE17 | IMMZ.Z.DE17 ValueSet for Rubella-containing vaccines |
| IMMZ.Z.DE18 | IMMZ.Z.DE18 ValueSet for Seasonal influenza vaccines |
| IMMZ.Z.DE19 | IMMZ.Z.DE19 ValueSet for Tetanus-containing vaccines |
| IMMZ.Z.DE2 | IMMZ.Z.DE2 ValueSet for Cholera vaccines |
| IMMZ.Z.DE20 | IMMZ.Z.DE20 ValueSet for TBE vaccines |
| IMMZ.Z.DE21 | IMMZ.Z.DE21 ValueSet for Typhoid vaccines |
| IMMZ.Z.DE22 | IMMZ.Z.DE22 ValueSet for Varicella-containing vaccines |
| IMMZ.Z.DE23 | IMMZ.Z.DE23 ValueSet for Yellow fever vaccines |
| IMMZ.Z.DE24 | IMMZ.Z.DE24 ValueSet for DTP-containing vaccines |
| IMMZ.Z.DE26 | IMMZ.Z.DE26 ValueSet for COVID-19 vaccines |
| IMMZ.Z.DE27 | IMMZ.Z.DE27 ValueSet for Malaria vaccines |
| IMMZ.Z.DE28 | IMMZ.Z.DE28 ValueSet for Tetanus and diphtheria-containing vaccines |
| IMMZ.Z.DE29 | IMMZ.Z.DE29 ValueSet for Pentavalent vaccines |
| IMMZ.Z.DE3 | IMMZ.Z.DE3 ValueSet for Diphtheria-containing vaccines |
| IMMZ.Z.DE30 | IMMZ.Z.DE30 ValueSet for Oral polio vaccines |
| IMMZ.Z.DE31 | IMMZ.Z.DE31 ValueSet for Inactivated polio vaccines |
| IMMZ.Z.DE32 | IMMZ.Z.DE32 ValueSet for Measles and rubella-containing vaccines |
| IMMZ.Z.DE34 | IMMZ.Z.DE34 ValueSet for Tetanus and diphtheria-containing vaccines (Td) |
| IMMZ.Z.DE4 | IMMZ.Z.DE4 ValueSet for Hib-containing vaccines |
| IMMZ.Z.DE5 | IMMZ.Z.DE5 ValueSet for Hepatitis A-containing vaccines |
| IMMZ.Z.DE6 | IMMZ.Z.DE6 ValueSet for Hepatitis B-containing vaccines |
| IMMZ.Z.DE7 | IMMZ.Z.DE7 ValueSet for HPV vaccines |
| IMMZ.Z.DE8 | IMMZ.Z.DE8 ValueSet for JE vaccines |
| IMMZ.Z.DE9 | IMMZ.Z.DE9 ValueSet for Measles-containing vaccines |
| IMMZ.Z.LiveAttenuated | IMMZ.Z.LiveAttenuated ValueSet for live attenuated vaccines |
| R5-medicinal-product-classification-for-R4B | Cross-version VS for R5.ProductClassification for use in FHIR R4B |
| medicinal-product-classification | Product Classification |
| il-core-medication-code | ILCore Medication Code |
| vaccine-product-code | Vaccine Product Codes |
| 2.16.840.1.113883.2.4.3.11.60.40.2.9.7.13--20200901000000 | IngredientCodeATCCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.11.1.4--20200901000000 | ProductCodeATCCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.9.7.7--20200901000000 | ProductCodeATCCodelijst |
| R5-medicinal-product-classification-for-R4 | Cross-version VS for R5.ProductClassification for use in FHIR R4 |
| cyehr-vs-ehdsiactiveingredient | Cyprus EHR Value Set: eHDSI Active Ingredient |
| cyehr-vs-ehdsivaccine | Cyprys EHR Value Set: eHDSI Vaccine |
| E_Rezept_Allergy_Substance_ACT | E_Rezept_Allergy_Substance_ACT |
| vs-drugs | Drugs |
| 2.16.840.1.113883.2.4.3.11.60.40.2.9.7.13--20171231000000 | IngredientCodeATCCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.11.1.4--20171231000000 | ProductCodeATCCodelijst |
| 2.16.840.1.113883.2.4.3.11.60.40.2.9.7.7--20171231000000 | ProductCodeATCCodelijst |
| myhealthway-allergyintolerance-substance-codes | MyHealthWay AllergyIntolerance Substance Codes |
No resources found
Note: links and images are rebased to the (stated) source
{
"resourceType": "CodeSystem",
"id": "atc",
"language": "en-US",
"text": {
"status": "empty",
"div": "<!-- snip (see above) -->"
},
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/resource-effectivePeriod",
"valuePeriod": {
"start": "2011-02-23T12:00:00Z"
}
}
],
"url": "http://www.whocc.no/atc",
"identifier": [
{
"use": "official",
"system": "urn:ietf:rfc:3986",
"value": "urn:oid:2.16.840.1.113883.6.73"
}
],
"version": "2011-02-23T12:00:00",
"name": "WHO_Anatomical_Therapeutic_Chemical_classification",
"title": "WHO Anatomical Therapeutic Chemical classification",
"status": "unknown",
"publisher": "ART-DECOR",
"description": "WHO ATC, Anatomical Therapeutic Chemical classification. The classification system divides drugs into different groups according to the organ or system on which they act and/or their therapeutic and chemical characteristics. It contains several subsets.",
"content": "not-present"
}